Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672661 | SCV000797788 | likely pathogenic | Glycogen storage disease type III | 2018-02-13 | criteria provided, single submitter | clinical testing | |
3billion | RCV000672661 | SCV003841823 | pathogenic | Glycogen storage disease type III | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with AGL related disorder (ClinVar ID: VCV000556632 / PMID: 19754354). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Genome- |
RCV000672661 | SCV004049999 | likely pathogenic | Glycogen storage disease type III | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000672661 | SCV005057496 | pathogenic | Glycogen storage disease type III | 2024-02-14 | criteria provided, single submitter | clinical testing |